References
- Beri R, Lourwood D L. Chemoprophylaxis for group B streptococcus transmission in neonates. Ann Pharmacother 1997; 31: 110–112
- Duff P. Antibiotic selection in obstetric patients. Infect Dis Clin North Am 1997; 11: 1–12
- Adair C D, Gunter M, Stovall T G, McElory G, Veille J C, Ernest J M. Chlamydia in pregnancy: A randomized trial of azithromycin and erythromycin. Obstet Gynecol 1998; 91: 165–168
- Williams J D, Sefton A M. Comparison of macrolide antibiotics. J Antimicrob Chemother 1993; 31(Suppl C)11–26
- Markham A, Faulds D. Roxithromycin. An update of its antimicrobial activity, pharmacokinetic properties and therapeutic use. Drugs 1994; 48: 297–326; 793
- Heikkinen T, Laine K, Neuvonen P J, Ekblad U. The transplacental transfer of the macrolide antibiotics erythromycin, roxithromycin and azithromycin. BJOG 2000; 107: 770–775
- Czeizel A E, Rockenbauer M, Olsen J, Sorensen H T. A case-control teratological study of spiramycin, roxithromycin, oleandomycin and josamycin. Acta Obstet Gynecol Scand 2000; 79: 234–237
- Weiner C P, Buhimschi C. Drugs for pregnant and lactating women. New York:, Churchill Livingstone 2004
- Briggs G G, Freeman R K, Yaffe S J. Drugs in pregnancy and lactation. 6th ed. Williams and Wilkins, BaltimoreUSA 2001
- Shepard T H. Catalog of teratogenic agents. 9th ed. John Hopkins University Press, BaltimoreUSA 1998